Compare Kenvue Inc. Common Stock (KVUE) vs Vanguard Ultra Short Bond ETF (VUSB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs Vanguard Ultra Short Bond ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Vanguard Ultra Short Bond ETF trades at $49.49 (market cap $10.20B). The key difference: Kenvue Inc. Common Stock is far larger — about 3.3× Vanguard Ultra Short Bond ETF's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Vanguard Ultra Short Bond ETF pays none. Which is the better fit depends on your goals.
| KVUE | VUSB | |
|---|---|---|
Market Cap | $34.06B | $10.20B |
Volume | 23,267,228 | 2,664,667 |
Sector | Consumer Staples | Leveraged / Inverse |
52-Week High | $19.83 | $50.03 |
52-Week Low | $14.11 | $49.41 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 62 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VUSB trades at $49.49, showing minimal daily movement with a 0.02% gain. Technical indicators signal a bearish trend, while recent news highlights short-term bond ETF appeal amid potential Fed rate hikes. The company has announced upcoming dividends, with three distributions scheduled for H2-2026.
The outlook remains cautious due to bearish technicals and interest rate sensitivity. Opportunities include dividend income, but risks involve Fed policy shifts and market volatility. Investors should weigh short-term stability against macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About Vanguard Ultra Short Bond ETF
VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →
